Published Research Findings

The findings of preclinical research on Oncocidia have been the subject of numerous published articles, notably:

 

Efficacy: 

  1. Proof-of-principle: Radiology 2011; 260:799-807
  2. Targetability & distribution: Theranostics 2012; 2:1010-19
  3. Survival probability: Theranostics 2013; 3:127-37

Safety:

  1. Iodinated hypericin: Acta Pharm Sinica 2012; 33:1549-56
  2. Solvent toxicities: XENOBIOTICA 2013;43(8):730-7
  3. Improved 131I-Hyp elimination: EBM 2013; 238:1437-49.

Formulations and Dosimetry:

  1. Necrosis avidity: Pharmaceutical Research 2014; 31: 278-90.
  2. µ vs co-dose: Anti-Cancer Agents in Medicinal Chemistry 2014
  3. Dosimetry: Simulating patients from rodents IJO 2014; 44: 819-29

General:

  1. Overview of OncoCiDia: Journal of Cancer 2013; 4:133-45